Conference Agenda
DxPx EU 2026
Location: Leonardo Royal Hotel Munich, Germany
February 5, 2026
Registration
DxPx Capital & Croissants
Join us at DxPx Investors-only breakfast. Free to join. No PowerPoints, no status pitches – just conversations that matter. New or lesser know VCs can contact us for a reverse pitch slot.
Location: Live Kitchen im ANDAZ MUNICH | Leopoldstraße 170, 80804 München, Germany
Investment Round tables
Six carefully selected diagnostics and biotools startups present to a closed circle of experienced VCs and industry investors. Each pitch is followed by extended, no-filter Q&A, giving founders direct feedback and investors a candid deep dive into strategy, traction, and investment readiness.
Agenda
- 08:30 - 09:00 Breakfast & introduction
- 09:00 - 10:30 First session
- 10:30 - 11:00 Networking break
- 11:00 - 12:30 Second session
Pitch. Inspire. Connect.
By: Merieux Equity Partners & DxPx
Registration
Dx & Biotools Market & Partnership Insights (MPI) Gain access to exclusive market data and strategic partnership opportunities within the Dx & Biotools sector. Price: €150
Welcome & Introduction
Topics
- Introduction to the MPI format and objectives
- Positioning of MPI within the DxPx ecosystem
- Overview of the agenda and contributors
L.E.K. Keynote Presentation | The Market Pulse – Global Growth & Investment Trends in Diagnostics & Biotools
Topics
- Overview of recent M&A transactions in Diagnostics & Biotools, including strategic vs. PE-led deal rationales
- Scale and value creation levers: platform strategies, operational excellence, and portfolio optimization
- Capital and transaction dynamics: funding availability, exit pathways, and valuation trends post-2024
- How acquirers and investors assess investment readiness and acquisition attractiveness in a maturing market
Executive Roundtable – Hosted & Moderated by L.E.K.
Topics
- Executive decision-making in scaling platforms
- Portfolio strategy and inorganic growth
- Value creation across the Dx & Biotools lifecycle
Health Advances Keynote
Competing in a Converging Market – Innovation, Partnerships, and Value Creation
Topics
- Evidence generation and market access strategies to ensure reimbursement rewards innovation
- Partnership models for development and commercialization
- Market creation tactics for enabling technologies supporting therapeutics/drugs
Executive Roundtable – Enabling Technologies Pharma Needs
Discussion focus
- Enabling diagnostics and biotools pharma actively seeks
- Integration into pharma R&D and clinical workflows
- Partnering expectations, collaboration models, and unmet needs
Closing Remarks & Transition
Capital 4 Growth Dinner
Join leading private equity investors and growth-stage executives for the launch of the DxPx Growth Track, positioning DxPx as Europe’s hub for later-stage companies in diagnostics, life science tools, and digital health.
Free participation for approved investors and companies with €5 M+ annual revenue — application required.
More PEs coming
Network Reception
The “Cocktails & Communication” reception marks the relaxed Kick off of the DxPx iwith an open bar, signature cocktails, and finger food — the perfect setting to reconnect with old friends, meet new partners, and toast to another year of deals and discoveries. Entry requires separate registration and a valid DxPX ticket.
February 6, 2026
Registration
Company pitches
Presenting companies: Amplifold, Elyte, Loop Dx, PL Bioscience
Expert Dialogs: European Sovereignty: Implications for the Healthcare System
Geopolitical shifts and supply-chain vulnerabilities have placed healthcare sovereignty at the top of Europe’s agenda. From critical raw materials to diagnostics, vaccines, and AI infrastructure, Europe faces the challenge of reducing dependencies while staying globally competitive. This panel examines the opportunities and trade-offs of European sovereignty, and how policy, innovation, and investment can safeguard access, resilience, and trust in healthcare.
Lunch
Expert Dialogs: Scaling Science: Private equity perspective on current market shifts
Private equity is fueling unprecedented growth in life science tools and biotools. This session gathers leading investors to explore valuation trends, platform strategies, and M&A dynamics shaping the sector. Insights will feed into a DxPx whitepaper, positioning this discussion as a must-read for startups, strategics, and investors.
Opening note for DxPx Pitch finals: From late stage funding to exit, my M&A journey
DxPx Business Plan Competition: Finalist Pitches
DxPx Pitch is a global pitch competition specifically for startups in the diagnostics, digital health, precision medicine, and life sciences tools sectors. It provides an opportunity for early and growth-stage companies to submit their business, get feedback, and compete for funding of up to $2 million.
Sundowner Cocktail Reception & DxPx Pitch Winner Announcement
Food & drinks provided for all participants along with the DxPx Capital Pitch winner announcement.
DxPx Pitch is a global pitch competition specifically for startups in the diagnostics, digital health, precision medicine, and life sciences tools sectors. It provides an opportunity for early and growth-stage companies to submit their business, get feedback, and compete for funding of up to $2 million.
Cash bar available following reception.
Date & Location:
Reception: Thursday, February 5th, 2026
Partnering Day & DxPx Pitch: February 6th, 2026
Leonardo Royal Munich
Moosacher Straße 90 | 80809 München | Germany
